A voluntary agreement between the Government and the pharmaceutical industry.
The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and delivery of life-enhancing and life-saving medicines.
The Association of the British Pharmaceutical Industry (ABPI) and the BioIndustry Association (BIA) have welcomed the publication of "Continuity in the availability of goods for the EU and the UK", published today by the UK Government's Department for Exiting the European Union.
As a membership organisation we work with our member companies, and the expertise of the specialists they employ, to develop and present our points of view to UK and European governments, the public and to other stakeholders.
A new report published on 18 July 2017 shows that the UK is trailing behind the rest of Europe in the treatment of cancer.
To launch the report, the ABPI gathered a panel of experts to reflect on the findings - with questions from an audience of patient groups and Life Sciences industry representatives.
This panel discussion features:
Read more about the report.